AN2 Therapeutics Inc (ANTX) financials · $32.0M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
AN2 Therapeutics Inc (ANTX) $32.0M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$38.1M | -$56.8M |
| Net Income | -$35.2M | -$51.3M |
| EPS (Diluted) | -$1.16 | -$1.72 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $62.0M | $92.1M |
| Current Assets | $59.9M | $86.3M |
| Cash & Equivalents | $19.9M | $21.4M |
| Total Liabilities | $8.89M | $10.2M |
| Current Liabilities | $8.72M | $10.2M |
| Shareholders' Equity | $53.1M | $81.8M |
| Retained Earnings | -$240.9M | -$205.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$29.8M | -$49.3M |
| Investing Cash Flow | $28.3M | $54.6M |
| Financing Cash Flow | $113.0K | $372.0K |
| Net Change in Cash | -$1.41M | $5.70M |
FAQ
What is ANTX P/E and revenue?
AN2 Therapeutics Inc (ANTX) $32.0M cap.
What is ANTX revenue?
ANTX income-statement cache has no revenue figure yet.
Is ANTX profitable?
AN2 Therapeutics Inc last cached net income is -$35.2M (FY2025).
What are ANTX total assets?
AN2 Therapeutics Inc last cached total assets are $62.0M (FY2025).
What is ANTX free cash flow?
No cached cash-flow row for ANTX yet.
Not investment advice. Cached statements, not a live tape.